Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Tarih

Yazarlar

Akay, Olga Meltem

Pehlivan, Mustafa

Yigenoglu, Tugce Nur

Elverdi, Tugrul

Kaynar, Leylagul

Ayyildiz, Orhan

Hindilerden, Ipek Yonal

Diğer Tanımlayıcı No

WOS:000691910500283

Yayınevi

CIG MEDIA GROUP, LP

Anahtar kelimeler

relapsed and refractory, Hodgkin lymphoma, brentuximab vedotin, autologous stem cell transplantation, consolidation

URI

https://openaccess.acibadem.edu.tr/handle/11443/7216

Koleksiyonlar

Tam öğe sayfası